ERN-EuroBloodNet
 
Newsletter - June 2023
 

Keep informed about the latest information on Rare Hematological Diseases!

 
 
NEWS
 
 
 
The ERN Preceptorship experience in Foundation IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan
 
 

Discover the experience of the coordinator and the participants!

 
 
Read more
 
 
 
 
DEADLINE EXTENDED - The ERN-EuroBloodNet is mapping the availability of PNH Drugs and its reimbursement states in European Member States
 
 

The results of this study will be used for a policy report delivered to policymakers and regulatory bodies.

 
 
Read more
 
 
 
 
ERN-EuroBloodNet European Mapping for management of Venous Thrombosis and Arterial Thrombosis in Pediatric Patients – DEADLINE EXTENDED until 31st July!
 
 

Is it time for an ERN-EuroBloodNet working group thrombosis? If you treat children with thrombosis, contribute to the mapping

 
 
Read more
 
 
 
 
  
Discover the outcomes of the ENROL closing meeting - 1st phase of the project!
 

The meeting has been held online last Wednesday 3rd of May 2023.

Read more
 
 
 
 
  
Do not miss next ERICA workshop focused on drug repurposing in rare diseases!
 

Participants can join the 7th of July meeting in person or online.

Read more
 
 
 
 
  
Click on the interactive ERN-EuroBloodNet poster for celebrating the 2023 World Sickle Cell Day!
 

Discover how the ERN fosters research, provides education and improves lives of individuals and families affected by this condition.

Read more
 
 
 
 
  
ERN-EuroBloodNet at the Sickle Cell Consortium 24 Hour celebration of World Sickle Cell Day
 

The ERN-EuroBloodNet invites you to participate at the 4th Annual World Sickle Cell Day – 24-Hour Sickle Cell-a-Thon!

Read more
 
 
 
 
  
The EHA Clinical Research Training in Hematology call is opened until July 18th!
 

Twenty early-career scientists will be selected to participate in the course.

Read more
 
 
 
 
  
Keep updated on ERN-EuroBloodNet actions through its communication channels!
 

Subscribe to the newsletter and follow us on Twitter, LinkedIn and Facebook!

Read more
 
 
 
© ERN-EuroBloodNet 2024